Randomized, comparative study of interferon β-1a treatment regimens in MS: the EVIDENCE trial H Panitch, DS Goodin, G Francis, P Chang, PK Coyle, P O’connor, ... Neurology 59 (10), 1496-1506, 2002 | 784 | 2002 |
Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up JP Zajicek, HP Sanders, DE Wright, PJ Vickery, WM Ingram, SM Reilly, ... Journal of Neurology, Neurosurgery & Psychiatry 76 (12), 1664-1669, 2005 | 431 | 2005 |
Heightened intrathecal release of axonal cytoskeletal proteins in multiple sclerosis is associated with progressive disease and clinical disability YK Semra, OA Seidi, MK Sharief Journal of neuroimmunology 122 (1-2), 132-139, 2002 | 161 | 2002 |
Overexpression of the apoptosis inhibitor FLIP in T cells correlates with disease activity in multiple sclerosis YK Semra, OA Seidi, MK Sharief Journal of neuroimmunology 113 (2), 268-274, 2001 | 88 | 2001 |
Interferon-β therapy downregulates the anti-apoptosis protein FLIP in T cells from patients with multiple sclerosis MK Sharief, YK Semra, OA Seidi, Y Zoukos Journal of neuroimmunology 120 (1-2), 199-207, 2001 | 73 | 2001 |
Expression ratios of the Bcl-2 family proteins and disease activity in multiple sclerosis MK Sharief, H Matthews, MA Noori Journal of neuroimmunology 134 (1-2), 158-165, 2003 | 55 | 2003 |
Upregulated survivin expression in activated T lymphocytes correlates with disease activity in multiple sclerosis MK Sharief, MA Noori, MR Douglas, YK Semra European journal of neurology 9 (5), 503-510, 2002 | 54 | 2002 |
Disease activity in multiple sclerosis correlates with T lymphocyte expression of the inhibitor of apoptosis proteins YK Semra, OA Seidi, MK Sharief Journal of neuroimmunology 122 (1-2), 159-166, 2002 | 50 | 2002 |
Expression of CD5 on B lymphocytes correlates with disease activity in patients with multiple sclerosis OA Seidi, YK Semra, MK Sharief Journal of neuroimmunology 133 (1-2), 205-210, 2002 | 48 | 2002 |
Down-regulation of survivin expression in T lymphocytes after interferon beta-1a treatment in patients with multiple sclerosis MK Sharief, YK Semra Archives of neurology 59 (7), 1115-1121, 2002 | 47 | 2002 |
Clinical aspects of malaria in the Asir region, Saudi Arabia GM Malik, O Seidi, A El-Taher, AS Mohammed Annals of Saudi medicine 18 (1), 15-17, 1998 | 47 | 1998 |
Contribution of noncommunicable diseases to medical admissions of elderly adults in Africa: a prospective, cross‐sectional study in Nigeria, Sudan, and Tanzania RO Akinyemi, IMH Izzeldin, C Dotchin, WK Gray, O Adeniji, OA Seidi, ... Journal of the American Geriatrics Society 62 (8), 1460-1466, 2014 | 44 | 2014 |
Neurology training in sub‐Saharan Africa: A survey of people in training from 19 countries FJ Mateen, SJ Clark, M Borzello, J Kabore, O Seidi Annals of neurology 79 (6), 871-881, 2016 | 37 | 2016 |
The expression of apoptosis-regulatory proteins in B lymphocytes from patients with multiple sclerosis OA Seidi, MK Sharief Journal of neuroimmunology 130 (1-2), 202-210, 2002 | 30 | 2002 |
Helicobacter pylori and Intestinal Metaplasia with Its Subtypes in the Gastric Antrum in a Saudi Population B Al-Knawy, N Morad, A Jamal, S Mirdad, MA Fotouh, ME Ahmed, ... Scandinavian journal of gastroenterology 34 (6), 562-565, 1999 | 22 | 1999 |
Deep Venous Thrombosis in Assir Region of Saudi Arabia Case-Control Study A Igbinovia, GM Malik, I Adetayo Grillo, OA Seidi, JU Egere, ... Angiology 46 (12), 1107-1113, 1995 | 20 | 1995 |
Pathergy test MR Baker, EV Smith, OA Seidi Practical neurology 11 (5), 301-302, 2011 | 13 | 2011 |
Acute mutism: a useful lesson M Maguire, O Seidi, M Baker, A Gupta, C Muwanga Emergency Medicine Journal 28 (1), 82-83, 2011 | 11 | 2011 |
Rare variant in LAMA2 gene causing congenital muscular dystrophy in a Sudanese family. A case report M Amin, Y BAkHIT, M KOkO, MOM Ibrahim, MA Salih, M Ibrahim, OA Seidi Acta Myologica 38 (1), 21, 2019 | 10 | 2019 |
Neurology training worldwide JM Hillis, AL Berkowitz Seminars in neurology 38 (02), 135-144, 2018 | 8 | 2018 |